Skip to main content
. 2024 Aug 19;13(16):4885. doi: 10.3390/jcm13164885

Table 3.

Baseline characteristics and image acquisition of patients undergoing cCT-A for TAVI planning stratified by the clinical endpoint.

Clinical Endpoint
Reached
(n = 80)		 Clinical Endpoint
Missed
(n = 21)		 p-Value
Age, years 81.6 [76.7–84.6]
(80/80)		 84.5 [77.9–88.9]
(21/21)		 0.067
Height, cm 165.3 ± 9.3
(80/80)		 168.1 ± 8.2
(21/21)		 0.216
Weight, kg 74.5 [65.0–88.0]
(80/80)		 67 [61.5–80.5]
(21/21)		 0.194
BMI, kg/m2 27.3 [24.2–31.1]
(80/80)		 24.5 [21.9–29.1]
(21/21)		 0.036
Male 31 (38.8%)
(80/80)		 14 (66.7%)
(21/21)		 0.022
Known coronary
artery disease		 29 (36.3%)
(80/80)		 15 (71.4%)
(21/21)		 0.004
Prior PCI 17 (21.3%)
(80/80)		 12 (57.1%)
(21/21)		 0.001
Arterial hypertension 69 (86.3%)
(80/80)		 18 (85.7%)
(21/21)		 0.950
Diabetes 23 (28.7%)
(80/80)		 5 (23.8%)
(21/21)		 0.653
Hyperlipidemia 49 (61.3%)
(80/80)		 12 (57.1%)
(21/21)		 0.732
ICD or pacemaker 3 (3.8%)
(80/80)		 1 (4.8%)
(21/21)		 0.832
COPD 5 (6.3%)
(80/80)		 1 (4.8%)
(21/21)		 0.797
Dialysis 0
(80/80)		 1 (4.8%)
(21/21)		 0.050
eGFR, mL/min 60 ± 20
(80/80)		 54 ± 20
(21/21)		 0.250
CKD stage
  • -

    1

  • -

    2

  • -

    3

  • -

    4

  • -

    5
4 (5.0%)
34 (42.5%)
38 (47.5%)
4 (5.0%)
0
(80/80)
1 (4.8%)
7 (33.3%)
11 (52.4%)
1 (4.8%)
1 (4.8%)
(21/21)		 0.375
Troponin T, ng/L 22 [15–73]
(80/80)		 29 [16–45]
(21/21)		 0.364
NT-pro BNP pg/L 1328 [536–4734]
(77/80)		 1587 [459–7993]
(21/21)		 0.396
LVEF
  • -

    >55%

  • -

    45–54%

  • -

    30–44%

  • -

    <30%
53 (66.3%)
6 (7.5%)
7 (8.8%)
14 (17.5%)
(80/80)
12 (57.1%)
4 (19.0%)
1 (4.8%)
4 (19.0%)
(21/21)		 0.422
Atrial fibrillation or flutter 36 (45.0%)
(80/80)		 13 (61.9%)
(21/21)		 0.168
Coronary CT-Angiography
Heart rate during acquisition, bpm 74 ± 12
(75/80)		 73 ± 13
(19/21)		 0.764
mAS 7932 [5968–9373]
(80/80)		 7593 [5360–9009]
(21/21)		 0.547
DLP, mGycm 640 [414–811]
(80/80)		 521 [299–677]
(21/21)		 0.098
Contrast, mL 76 [71–86]
(80/80)		 71 [71–76]
(21/21)		 0.007
Cardiac mass, g 195 [167–246]
(80/80)		 173 [137–215]
(21/21)		 0.098
Invasive Coronary Angiography
Coronary artery disease
none
1-vessel
2-vessel
3-vessel
45 (56.3%)
10 (12.5%)
7 (8.8%)
18 (22.5%)
(80/80)
3 (14.3%)
6 (28.6%)
5 (23.8%)
7 (33.3%)
(21/21)		 0.005

BMI = body mass index, bpm = beats per minute, cCTA = computed coronary tomography angiography, COPD = chronic obstructive pulmonary disease, CKD = chronic kidney disease, DLP = dose length product, eGFR = estimated glomerular filtration rate, ICA = invasive coronary angiography, ICD = implantable cardioverter defibrillator, LVEF = left ventricular ejection fraction, mAs = milliampere-seconds, PCI = percutaneous coronary intervention, TAVI = transcatheter aortic valve implantation. p-values < 0.05 are presented bold. Data availability is displayed in brackets below for each variable.